BackMedicenna Therapeutics Overview

Medicenna Therapeutics EBIT

EBIT (Earnings Before Interest and Taxes) analysis for MDNA.

Quarterly EBIT

-$6.81M
↑ 4.15% YoY

As of Sep 30, 2023

Annual EBIT (TTM)

-$22.58M
↓ 15.28% YoY

Trailing 12 months ending Sep 30, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin